Our website is in transition, if you are unable to locate a specific product please contact us.
Exhibitor Seminar | Epredia
Close
Close Choose language
Select

Exhibitor Seminar

Overview

Title: Exhibitor Seminar: Epredia - Multiplex immunofluorescence IHC is a powerful technique to address increasing research needs in immuno-oncology to better understand tumor environment (exhibitor webinar)

Available On Demand

Watch Now

By clicking next, I confirm I have read the privacy policy.

Program Information

Exhibitor Seminar

In this webinar, we will present a rapid, automated, high-plex fluorescent immunostaining procedure using the microfluidic-based staining device, LabSat® Research, and TSA staining reagents. The 6-marker protocol could be performed in less that 4 hours and 30 minutes, resulting in high quality marker detection, efficient removal of antibodies and remarkable signal uniformity. Create a more on-demand workflow by combining rapid immunohistochemistry with digital pathology and reduce your total time by 50-60%, boosting your lab’s efficiency and promoting more consistency in collaborative research.

Join us and experience how these technologies can improve your research activities.

Presenter Information

Barbara Cahill

Barbara Cahill is the Sr. Global Portfolio Manager for Immunohistochemistry, Consumables and Cytology at Epredia, a global precision cancer diagnostics company working to improve patient outcomes by providing groundbreaking technologies. Barbara is an accomplished marketer who has accelerated new product development initiatives in the life sciences and self-care industries for almost 20 years. Her experiences enable her to transform and lead with market disruptive technologies that personally and professionally align with Epredia’s mission and vision to improve lives by enhancing precision cancer diagnostics.

Chris Coley

Chris Coley is the Global Marketing Development Manager for Digital Pathology at Epredia, a global precision cancer diagnostics company working to improve patient outcomes by providing groundbreaking technologies. Chris has an extensive Anatomical Pathology background followed by various roles in sales and marketing for comprehensive product lines in the both clinical and research segments for over 25 years. His experiences enable him to implement market enhancing technologies that professionally align with Epredia’s mission and vision to improve lives by enhancing precision cancer diagnostics.

Close

You are leaving the full Epredia.com website. You will be redirected to the [language] site with limited information on our solutions for your laboratory. For more information please fill out the 'contact us' form and a sales representative will answer all of your questions.

Go Back
Continue

您将离开我们的完整网站。 您将被重定向到中文站点,其中包含有关我们为您的实验室解决方案的有限信息。如需更多信息,请填写“联系我们”表格,销售代表将回答您的所有问题。

后退
继续